The association between homocysteine and systemic sclerosis: A review of the literature and meta-analysis

Reference

• Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism Collaborative Initiative. Arthritis Rheumatol. 2013;72(11):1747–55.
   Google Scholar
• Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest. 2007;117(3):557–67.
   PubMed Web of Science ®Google Scholar
• Lai WK, Kan MY. Homocysteine-induced endothelial dysfunction. Ann Nutr Metab. 2015;67(1):1–12.
   PubMed Web of Science ®Google Scholar
• Ajith TA. Ranimenon. Homocysteine in ocular diseases. Clin Chim Acta. 2015;450:316–21.
   PubMed Web of Science ®Google Scholar
• Taheraghdam AA, Dalirakbari N, Khalili M, et al. Hyperhomocysteinemia, low vitamin B12, and low folic acid: are risk factors of cerebral vascular thrombosis in northwest Iran? J Res Med Sci. 2016;21(1):16.
   PubMed Web of Science ®Google Scholar
• Yeh JK, Chen CC, Hsieh MJ, Tsai ML, Yang CH, Chen DY, et al. Impact of homocysteine level on long-term cardiovascular outcomes in patients after coronary artery stenting. J Atheroscler Thromb. 2016;24:696–705.
   PubMed Web of Science ®Google Scholar
• Shanshan S, Guifan S. The relationship between hyperhomocysteinemia and type 2 diabetes mellitus. Chin J Dis Control Prev. 2011;15(11):997–1001. (In Chinese)
   Google Scholar
• Kundi H, Kiziltunc E, Ates I, Cetin M, Barca AN, Ozkayar N, et al. Association between plasma homocysteine levels and end-organ damage in newly diagnosed type 2 diabetes mellitus patients. Endocr Res. 2017;42(1):36–41.
   PubMed Web of Science ®Google Scholar
• Ortiz TT, Terreri MT, Caetano M, Souza FS, D'Almeida V, Sarni ROS, et al. Dyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations. Ann Nutr Metab. 2013;63(1–2):77–82.
   PubMed Web of Science ®Google Scholar
• Yang X, Gao F, Liu Y. Association of homocysteine with immunological-inflammatory and metabolic laboratory markers and factors in relation to hyperhomocysteinaemia in rheumatoid arthritis. Clin Exp Rheumatol. 2015;33(6):900–3.
   PubMed Web of Science ®Google Scholar
• Vayá A, Sánchez F, Todolí J, Calvo J, Alis R, Collado S, et al. Homocysteine levels in patients with primary and secondary Raynaud's phenomenon. Its association with microangiopathy severity. Clin Hemorheol Microcirc. 2014;56(2):153–9.
   PubMed Web of Science ®Google Scholar
• Caramaschi P, Martinelli N, Biasi D, Carletto A, Faccini G, Volpe A, et al. Homocysteine plasma concentration is related to severity of lung impairment in scleroderma. J Rheumatol. 2003;30(2):298–304.
   PubMed Web of Science ®Google Scholar
• Caramaschi P, Canestrini S, Martinelli N, Volpe A, Pieropan S, Ferrari M, et al. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology [Oxford]. 2007;46(10):1566–9.
   PubMed Web of Science ®Google Scholar
• Khurma V, Meyer C, Park GS, McMahon M, Lin J, Singh RR, et al. A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls. Arthritis Rheum. 2008;59(4):591–7.
   PubMedGoogle Scholar
• Motegi S, Toki S, Yamada K, Uchiyama A, Ishikawa O. Elevated plasma homocysteine level is possibly associated with skin sclerosis in a series of Japanese patients with systemic sclerosis. J Dermatol. 2014;41(11):986–91.
   PubMed Web of Science ®Google Scholar
• Szamosi S, Csiki Z, Szomják E, Szolnoki E, Szőke G, Szekanecz Z, et al. Plasma homocysteine levels, the prevalence of methylenetetrahydrofolate reductase gene C677T polymorphism and macrovascular disorders in systemic sclerosis: risk factors for accelerated macrovascular damage? Clinic Rev Allerg Immunol. 2009;36(2–3):145–9.
   PubMed Web of Science ®Google Scholar
• Nazarinia M, Shams M, Kamali Sarvestani E, Shenavande S, Khademalhosseini M, Khademalhosseini Z, et al. Serum homocystein level in patients with scleroderma. Iran Red Crescent Med J. 2013;15(1):29–31.
   PubMed Web of Science ®Google Scholar
• Peterlana D, Puccetti A, Caramaschi P, Biasi D, Beri R, Simeoni S, et al. Endothelin-1 serum levels correlate with MCP-1 but not with homocysteine plasma concentration in patients with systemic sclerosis. Scand J Rheumatol. 2006;35(2):133–7.
   PubMed Web of Science ®Google Scholar
• Whitlock RP, Chan S, Devereaux PJ, Sun J, Rubens FD, Thorlund K, et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. Eur Heart J. 2008;29(21):2592–600.
   PubMed Web of Science ®Google Scholar
• Levy Y, George J, Langevitz P, Harats D, Doolman R, Sela BA, et al. Elevated homocysteine levels in patients with Raynaud's syndrome. J Rheumatol. 1999;26(11):2383–5.
   PubMed Web of Science ®Google Scholar
• Marasini B, Casari S, Bestetti A, Maioli C, Cugno M, Zeni S, et al. Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon. J Rheumatol. 2000;27(11):2621–3.
   PubMed Web of Science ®Google Scholar
• Sabio JM, Vargas-Hitos JA, Martinez-Bordonado J, Navarrete-Navarrete N, Díaz-Chamorro A, Olvera-Porcel C, et al. Relationship between homocysteine levels and hypertension in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2014;66(10):1528–35.
   PubMed Web of Science ®Google Scholar
• Cutolo M, Pizzorni C, Sulli A. Capillaroscopy. Best Pract Res Clin Rheumatol. 2005;19:437–52.
   PubMed Web of Science ®Google Scholar
• Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheumatol. 2013;65(8):1953–62.
   PubMed Web of Science ®Google Scholar
• Kutilek S, Nemec V, Bockayova E. Elevated serum homocysteine levels in paediatric patients with primary Raynaud’s phenomenon. Rev Bras Reumatol. 2012;52(1):128–30.
   PubMed Web of Science ®Google Scholar
• Kumar T, Sharma GS, Singh LR. Homocystinuria: therapeutic approach. Clin Chim Acta. 2016;458:55–62.
   PubMed Web of Science ®Google Scholar
• Ma J, Chen Z, Chen S, Peng X, Liu S, Zhao D, et al. [A prospective study on the association of plasma homocysteine level with stroke in hypertensive patients]. Zhonghua Nei Ke Za Zhi. 2015;54(4):296–301.
   PubMedGoogle Scholar
• Chen S, Guo X, Dong S, Li Z, Sun Y. Relationship between lifestyle factors and hyperhomocysteinemia in general Chinese population: a cross-sectional study. Postgrad Med. 2017;129(2):216–23.
   PubMed Web of Science ®Google Scholar
• Rodgers GM, Conn MT. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood. 2009;75:895–901.
   Google Scholar
• Dayal S, Wilson KM, Leo L, Arning E, Bottiglieri T, Lentz SR. Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia. Blood. 2006;108:2237–43.
   PubMed Web of Science ®Google Scholar
• Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease: enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17:2074–81.
   PubMed Web of Science ®Google Scholar
• Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;91:308–18.
   PubMed Web of Science ®Google Scholar
• Lentz SR. Mechanisms of thrombosis in hyperhomocysteinemia. Curr Opin Hematol. 1998;5:343–9.
   PubMedGoogle Scholar
• Devi S, Kennedy RH, Joseph L, Shekhawat NS, Melchert RB, Joseph J, et al. Effect of long-term hyperhomocysteinemia on myocardial structure and function in hypertensive rats. Cardiovasc Pathol. 2006;15:75–82.
   PubMed Web of Science ®Google Scholar
• Matte C, Stefanello FM, Mackedanz V, Pederzolli CD, Lamers ML, Dutra-Filho CS, et al. Homocysteine induces oxidative stress, inflammatory infiltration, fibrosis and reduces glycogen/glycoprotein content in liver of rats. Int J Dev Neurosci. 2009;27:337–44.
   PubMed Web of Science ®Google Scholar
• Raaf L, Noll C, Cherifi MH, Samuel J-L, Delcayre C, Delabar J-M, et al. Myocardial fibrosis and TGFB expression in hyperhomocysteinemic rats. Mol Cell Biochem. 2011;347:63–70.
   PubMed Web of Science ®Google Scholar
• Casciola-Rosen L, Wigley F, Rosen A. Scleroderma autoantigens are uniquely fragmented by metal catalyzed oxidation reactions: implications for pathogenesis. J Exp Med. 1997;185:171–9.
   PubMed Web of Science ®Google Scholar
• Bruckdorfer KR, Hillary JB, Bunce T, Vancheeswaran R, Black CM. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum. 1995;38:1060–7.
   PubMed Web of Science ®Google Scholar
• Joseph J, Joseph L, Devi S, Kennedy RH. Effect of anti-oxidant treatment on hyperhomocysteinemia-induced myocardial fibrosis and diastolic dysfunction. J Heart Lung Transpl. 2008;27:1237–41.
   PubMed Web of Science ®Google Scholar
• Yi F, Li PL. Mechanisms of homocysteine-induced glomerular injury and sclerosis. Am J Nephrol. 2008;28:254–64.
   PubMed Web of Science ®Google Scholar
• Latella G, Rogler G, Bamias G, Breynaert C, Florholmen J, Pellino G, et al. Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. J Crohns Colitis. 2014;8(10):1147–65.
   PubMed Web of Science ®Google Scholar
• Torres L, García-Trevijano ER, Rodríguez JA, Carretero MV, Bustos M, Fernández E, et al. Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis. Biochim Biophys Acta. 1999;1455(1):12–22.
   PubMed Web of Science ®Google Scholar
• Ding H, Gan HZ, Fan WJ, Cao L-Y, Xu J-M, Mei Q, et al. Homocysteine promotes intestinal fibrosis in rats with trinitrobenzene sulfonic acid-induced colitis. Dig Dis Sci. 2015;60(2):375–81.
   PubMed Web of Science ®Google Scholar
• García-Tevijano ER, Berasain C, Rodríguez JA, Corrales FJ, Arias R, Martín-Duce A, et al. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis. Hypertension. 2001;38(5):1217–21.
   PubMed Web of Science ®Google Scholar
• Sen U, Moshal KS, Tyagi N, Kartha GK, Tyagi SC. Homocysteine-induced myofibroblast differentiation in mouse aortic endothelial cells. J Cell Physiol. 2006;209(3):767–74.
   PubMed Web of Science ®Google Scholar
• Lei W, Long Y, Li S, Liu Z, Zhu F, Hou FF, et al. Homocysteine induces collagen I expression by downregulating histone methyltransferase G9a. PLoS One. 2015;10(7):e0130421.
   PubMed Web of Science ®Google Scholar